✦ LIBER ✦

Focus: Long-term treatment with lamivudine in HBeAg negative patients with chronic hepatitis B: To switch or not to switch?

✍ Scribed by Daniel Shouval

Book ID: 116652753
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 162 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.03.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B surface antigen seroconversi

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients

✍ R. Idilman; K. Cinar; G. Seven; Y. Bozkus; A. Elhan; M. Bozdayi; C. Yurdaydin; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Efficacy of switching to telbivudine in

Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

✍ Rifaat Safadi; Qing Xie; Yagang Chen; You-Kuan Yin; Lai Wei; Seong Gyu Hwang; El 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Effect of lamivudine treatment in patien

Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B

✍ Nikolaos Nikolaidis; Themistoklis Vassiliadis; Olga Giouleme; Konstantinos Tziom 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

470 HBeAg negative patients with chronic

470 HBeAg negative patients with chronic hepatitis B are less likely to have A biochemical breakthrough during lamivudine treatment

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Long term efficacy of interferon and thy

Long term efficacy of interferon and thymosin combination in comparison to lamivudine+interferon and interferon monotherapy in patients with HBEAG negative chronic hepatitis B

✍ M. Saruc; N. Ozden; N. Turkel; L.M. Hock; S. Ayhan; I. Tuzcuoglu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Efficacy of adefovir add-on lamivudine r

Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B

✍ Han Jak Ryu; Jung Min Lee; Sang Hoon Ahn; Do Young Kim; Myoung Ha Lee; Kwang-Hyu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract No study has reported on the comparative effect of adefovir (ADV) add‐on lamivudine (LAM) versus switching to entecavir (ETV) in LAM‐resistant patients with chronic hepatitis B. From October 2007 to September 2008, 92 consecutive LAM‐resistant patients were enrolled (47 LAM + ADV and 45